DEA updates rules for prescribing opioid addiction medications outside specialized clinics
/ 1 min read
Table of Contents
The Drug Enforcement Administration has finalized regulations that change how doctors, nurse practitioners, and other licensed providers can prescribe medications for opioid use disorder. These changes remove the old requirement that individual practitioners get a special waiver to treat up to 30 patients with certain controlled substances like buprenorphine.
Why it matters: This rule removes administrative barriers that previously limited how many patients a single doctor could treat with opioid addiction medications. By replacing patient caps with training requirements, the government aims to expand access to treatment without creating new regulatory hurdles for providers who are already qualified. It is mostly an update to compliance standards rather than a change in medical practice.
Who it affects
- Physicians, nurse practitioners, physician assistants, and other licensed prescribers who treat opioid use disorder
This final rule was issued by the Drug Enforcement Administration; readers should check the original Federal Register document for full legal text and compliance details.
Agency: Justice Department, Drug Enforcement Administration
Source: Federal Register — read the official document